| P50 | author | Bernard Le Foll | Q28480403 |
| | Paola Fadda | Q59506111 |
| | Gianluigi Tanda | Q44736132 |
| P2093 | author name string | Steven R Goldberg | |
| | Maria Scherma | |
| | Walter Fratta | |
| | Benoit Forget | |
| P2860 | cites work | Long term pharmacotherapy for obesity and overweight: updated meta-analysis. | Q22242086 |
| | Nicotine receptor partial agonists for smoking cessation | Q24242786 |
| | Nicotine receptor partial agonists for smoking cessation | Q24246525 |
| | Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 |
| | Cannabinoid receptor localization in brain | Q24558751 |
| | 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor | Q24620096 |
| | Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors | Q24642509 |
| | GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current | Q24653442 |
| | The orphan receptor GPR55 is a novel cannabinoid receptor | Q24670137 |
| | Marijuana and cannabinoid regulation of brain reward circuits | Q24671514 |
| | Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. | Q24681363 |
| | Addiction, dopamine, and the molecular mechanisms of memory | Q28142501 |
| | Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 |
| | Role of endogenous cannabinoids in synaptic signaling | Q28185075 |
| | Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence | Q28200994 |
| | Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 |
| | Cannabinoid CB1 receptors control conditioned drug seeking | Q28259415 |
| | Allosteric modulation of the cannabinoid CB1 receptor | Q28268355 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 |
| | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 |
| | Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 |
| | Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 |
| | Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists | Q28348765 |
| | Limbic activation during cue-induced cocaine craving | Q28369526 |
| | Stress-induced craving and stress response in cocaine dependent individuals | Q28374775 |
| | High reinforcing efficacy of nicotine in non-human primates | Q28469129 |
| | Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice | Q28506626 |
| | The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion | Q28511348 |
| | Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei | Q28564628 |
| | Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat | Q28583983 |
| | Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine | Q28589593 |
| | Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs | Q29301836 |
| | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| | The molecular logic of endocannabinoid signalling | Q29615356 |
| | Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | The reinstatement model of drug relapse: history, methodology and major findings | Q29616241 |
| | Dopamine, learning and motivation | Q29616245 |
| | International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 |
| | Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 |
| | Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 |
| | Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain | Q30047898 |
| | Localization of drug reward mechanisms by intracranial injections | Q35970774 |
| | Nicotine: from molecular mechanisms to behaviour | Q36015617 |
| | Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. | Q36119168 |
| | The role of the cannabinoid system in nicotine addiction. | Q36144660 |
| | Endocannabinoid signaling system and brain reward: emphasis on dopamine | Q36152336 |
| | Nicotine as a typical drug of abuse in experimental animals and humans. | Q36277268 |
| | Guidance for research and testing to reduce tobacco toxicant exposure | Q36317922 |
| | Neural mechanisms of drug reinforcement | Q36330262 |
| | Nicotine and nonnicotine factors in cigarette addiction | Q36345893 |
| | Endocannabinoids in the central nervous system: from neuronal networks to behavior | Q36352196 |
| | Neuropharmacology and potential efficacy of new treatments for tobacco dependence | Q36376434 |
| | Tobacco addiction | Q36519493 |
| | Brain nicotinic acetylcholine receptors: native subtypes and their relevance. | Q36550823 |
| | Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system | Q36607367 |
| | Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain | Q36653994 |
| | In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission | Q36686455 |
| | The endocannabinoid system in brain reward processes | Q36741861 |
| | Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions | Q36830438 |
| | Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. | Q36873051 |
| | Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence | Q36950936 |
| | Hippocampal interneurons co-express transcripts encoding the alpha7 nicotinic receptor subunit and the cannabinoid receptor 1 | Q36952150 |
| | The neurobiology of tobacco addiction | Q36966993 |
| | Endocannabinoid regulation of relapse mechanisms | Q36970902 |
| | Allosterism and cannabinoid CB(1) receptors: the shape of things to come | Q37009188 |
| | Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties | Q37031056 |
| | The endocannabinoid system: emotion, learning and addiction | Q37142237 |
| | Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development | Q37143586 |
| | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats | Q37146387 |
| | Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies | Q37164812 |
| | Cannabinoid receptor 1 gene association with nicotine dependence | Q37322610 |
| | The endogenous cannabinoid system modulates nicotine reward and dependence | Q37353755 |
| | Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 |
| | Preclinical assessment of abuse liability of drugs | Q39635211 |
| | A psychomotor stimulant theory of addiction. | Q39681407 |
| | Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide | Q48247701 |
| | Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action | Q48309971 |
| | The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport | Q48315882 |
| | Cannabinoids modulate potassium current in cultured hippocampal neurons. | Q48388103 |
| | The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. | Q48481302 |
| | Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 |
| | Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. | Q48510920 |
| | Nicotine activates and desensitizes midbrain dopamine neurons | Q48590165 |
| | Brain sites mediating the discriminative stimulus effects of nicotine in rats | Q48950640 |
| | Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. | Q51375099 |
| | Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. | Q51375624 |
| | Long-term potentiation of excitatory inputs to brain reward areas by nicotine. | Q51381056 |
| | Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. | Q51571790 |
| | Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. | Q51627333 |
| | Control of behavior by intravenous nicotine injections in laboratory animals. | Q51850356 |
| | Computerised therapy for psychiatric disorders. | Q51901557 |
| | Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. | Q52016680 |
| | Reinstatement and spontaneous recovery of nicotine seeking in rats. | Q52195387 |
| | Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. | Q52197424 |
| | Nicotine reinstatement of nicotine self-administration after long-term extinction. | Q52200047 |
| | Nicotine-induced place preferences following prior nicotine exposure in rats. | Q52220497 |
| | Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. | Q52248899 |
| | Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. | Q52277162 |
| | Nicotine as a reinforcer in human subjects and laboratory animals. | Q52278630 |
| | Persistent behavior at high rates maintained by intravenous self-administration of nicotine. | Q52292036 |
| | Endocannabinoids | Q55282369 |
| | Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study | Q60209721 |
| | Stimuli associated with drug injections as events that control behavior | Q67520426 |
| | Rodent model of nicotine abstinence syndrome | Q67591174 |
| | Genetic influence on smoking--a study of male twins | Q68022601 |
| | Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process | Q71693466 |
| | Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide | Q71743278 |
| | Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain | Q71988975 |
| | Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization | Q72631582 |
| | Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) | Q73011648 |
| | Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse | Q73554155 |
| | The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study | Q73572188 |
| | A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study | Q73661239 |
| | Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas | Q73689123 |
| | Presynaptic nicotinic receptors modulating dopamine release in the rat striatum | Q73689125 |
| | No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population | Q73816360 |
| | The alpha4beta2 agonist SIB 1765F, but not the alpha7 agonist AR-R 17779, cross-sensitises to the psychostimulant effects of nicotine | Q74043409 |
| | Stress-induced relapse to heroin and cocaine seeking in rats: a review | Q74248968 |
| | Tobacco dependence treatments: review and prospectus | Q74610223 |
| | Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence | Q80167784 |
| | Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats | Q82900089 |
| | Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome. | Q30366778 |
| | Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. | Q30493991 |
| | Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data | Q30807024 |
| | Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. | Q31813503 |
| | Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse | Q31863511 |
| | Overview of nicotinic receptors and their roles in the central nervous system | Q32076973 |
| | Dysregulation of the endocannabinoid system in obesity | Q33345484 |
| | Pain modulation by release of the endogenous cannabinoid anandamide | Q33421146 |
| | Nicotinic receptors in the brain. Links between molecular biology and behavior. | Q33872186 |
| | Role of dopamine in the behavioural actions of nicotine related to addiction | Q33894548 |
| | Alteration of the behavioral effects of nicotine by chronic caffeine exposure. | Q33933548 |
| | Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 |
| | Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. | Q33951646 |
| | Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 |
| | A missense mutation in human fatty acid amide hydrolase associated with problem drug use. | Q34032872 |
| | Brain monoamine oxidase A inhibition in cigarette smokers | Q34063791 |
| | US public health service clinical practice guideline: treating tobacco use and dependence. | Q34072032 |
| | Genes and addiction | Q34076144 |
| | The fatty acid amide hydrolase (FAAH). | Q34098981 |
| | Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids | Q34166712 |
| | Conditioned place preference: what does it add to our preclinical understanding of drug reward? | Q34188090 |
| | Assembly and subunit diversity of nicotinic acetylcholine receptors | Q34217965 |
| | Nicotine induces conditioned place preferences over a large range of doses in rats. | Q34402486 |
| | Evidence for novel cannabinoid receptors | Q34415409 |
| | Modulation of transmitter release via presynaptic cannabinoid receptors | Q34430714 |
| | Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 |
| | Use of knock-out mice to determine the molecular basis for the actions of nicotine | Q34478329 |
| | The genetic epidemiology of smoking | Q34478414 |
| | Involvement of the endocannabinoid system in drug addiction | Q34495242 |
| | Cellular mechanisms of nicotine addiction | Q34498016 |
| | Cue dependency of nicotine self-administration and smoking. | Q34498025 |
| | Nicotine dependence: studies with a laboratory model | Q34498036 |
| | Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors | Q34532228 |
| | Neurobiology of relapse to heroin and cocaine seeking: a review | Q34547387 |
| | Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study | Q34556870 |
| | Non-nicotinic therapies for smoking cessation. | Q34599269 |
| | Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. | Q34605939 |
| | Cannabinoid addiction: behavioral models and neural correlates. | Q34616145 |
| | Treatment of tobacco dependence: integrating recent progress into practice | Q34715360 |
| | Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 |
| | Cellular and synaptic mechanisms of nicotine addiction | Q35000325 |
| | The genetic determinants of smoking | Q35124903 |
| | Twin concordance for a binary trait. II. Nested analysis of ever-smoking and ex-smoking traits and unnested analysis of a "committed-smoking" trait | Q35200130 |
| | Nicotine as a modulator of behavior: beyond the inverted U. | Q35216455 |
| | Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction | Q35541262 |
| | Neuroadaptive effects of active versus passive drug administration in addiction research. | Q35579511 |
| | Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion | Q35613704 |
| | Current pharmacological treatments for nicotine dependence | Q35629258 |
| | Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens | Q35682043 |
| | The endocannabinoid system and its therapeutic exploitation | Q35876026 |
| | Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. | Q35938826 |
| | Cannabinoids and gene expression during brain development. | Q35950914 |
| | Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration | Q40263092 |
| | The scientific case that nicotine is addictive. | Q40510452 |
| | Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders | Q40955351 |
| | Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace | Q41295074 |
| | Molecular Aspects of Cannabinoid Receptors | Q41519833 |
| | The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats | Q41962278 |
| | Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. | Q42154370 |
| | Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain | Q42281865 |
| | Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry | Q42471010 |
| | A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain | Q42539487 |
| | Cannabinoid receptor gene (CNR1): association with i.v. drug use. | Q42550174 |
| | Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats | Q42661076 |
| | Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease | Q43504648 |
| | Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers | Q43549140 |
| | Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals | Q43574291 |
| | Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. | Q43641975 |
| | A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues | Q43715532 |
| | Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. | Q43742950 |
| | GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. | Q43794898 |
| | Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 |
| | Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats | Q44086486 |
| | Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. | Q44182704 |
| | Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine | Q44189376 |
| | SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats | Q44190296 |
| | Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation | Q44229738 |
| | Nicotine maintains robust self-administration in rats on a limited-access schedule | Q44290531 |
| | Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor | Q44303656 |
| | Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 |
| | Classically conditioned responses in opioid and cocaine dependence: a role in relapse? | Q44348701 |
| | A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. | Q44350045 |
| | Subsecond dopamine release promotes cocaine seeking. | Q44398175 |
| | The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes | Q44453346 |
| | Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. | Q44545264 |
| | Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. | Q44723162 |
| | Dopamine operates as a subsecond modulator of food seeking. | Q44762650 |
| | Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers | Q44784239 |
| | Neuroscience of addiction | Q44880443 |
| | CNR1 variation modulates risk for drug and alcohol dependence | Q44896757 |
| | The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice | Q44916561 |
| | Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse | Q45004332 |
| | Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). | Q45006435 |
| | The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride | Q45047801 |
| | Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. | Q45108517 |
| | Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats | Q45117312 |
| | Neuroscience. What genes tell us about nicotine addiction | Q45140704 |
| | Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice | Q45153251 |
| | The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity | Q45171657 |
| | Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 |
| | Endogenous cannabinoid signaling | Q46128123 |
| | (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. | Q46385269 |
| | Altered Fos expression in neural pathways underlying cue-elicited drug seeking in the rat. | Q46425139 |
| | Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. | Q46499076 |
| | Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors | Q46586967 |
| | beta2-Subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice | Q46679002 |
| | Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia | Q46807918 |
| | Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes | Q46808737 |
| | The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats | Q46870466 |
| | Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues | Q46911648 |
| | A neutral CB1 receptor antagonist reduces weight gain in rat. | Q46932962 |
| | Are weight concerns predictive of smoking cessation? A prospective analysis | Q47308290 |
| | Understanding the relations between smoking and body weight and their importance to smoking cessation and relapse | Q47420228 |
| | Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study | Q47585426 |
| | Nicotine-induced limbic cortical activation in the human brain: a functional MRI study | Q47704131 |
| | Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling | Q48142913 |
| | Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine | Q48205587 |
| P433 | issue | 5 | |
| P921 | main subject | endocannabinoid system | Q368952 |
| P304 | page(s) | 468-481 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | CNS and Neurological Disorders | Q15724632 |
| P1476 | title | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction | |
| P478 | volume | 7 | |